"The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.
Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimm"...
DOSAGE AND ADMINISTRATION
Apply a thin film of CUTIVATE® Lotion to the affected skin areas once daily. Rub in gently.
Discontinue use when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
The safety and efficacy of CUTIVATE® Lotion have not been established beyond 4 weeks of use.
Avoid use with occlusive dressings or application to the diaper area [see WARNINGS AND PRECAUTIONS].
CUTIVATE® Lotion is for topical use only, and not for ophthalmic, oral, or intravaginal use.
Dosage Forms And Strengths
Lotion, 0.05%. Each gram of CUTIVATE Lotion contains 0.5 mg fluticasone propionate in a white to off-white lotion base. CUTIVATE® Lotion is supplied in 120 mL bottles.
Storage And Handling
CUTIVATE® (fluticasone propionate) Lotion, 0.05% is white to off-white in color, and supplied as follows:
120 mL bottle NDC 10337-434-04
Store between 15° and 30°C (59° and 86° F).
Do not refrigerate, and keep container tightly closed.
Distributed by: PharmaDerm, a division of Fougera Pharmaceuticals Inc., Melville, New York 11747. Revised: Jan 2015This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/28/2015
Additional Cutivate Lotion Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.